Dual‐Responsive Supramolecular Polymeric Nanomedicine for Self‐Cascade Amplified Cancer Immunotherapy
Advanced Science · 2024
DOI: 10.1002/advs.202305382 ↗Kurz gefasst
Fachartikel in der Zeitschrift Advanced Science, 2024. Verfasst von Wenting Hu und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Hepatobiliary and Pancreatic Surgery, The Second Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, Zhejiang, 31000…. Hauptthemen laut MEDLINE: Immunotherapy, Nanomedicine, Tumor Microenvironment, Polymers. Die Arbeit wurde bisher 40-mal zitiert (Crossref) und nennt 54 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Natural Science Foundation of China, Zhejiang University Basic Research Fund, Plan Project of Wenzhou Municipal Science and Technology.
Abstract (Originalsprache)
Insufficient tumor immunogenicity and immune escape from tumors remain common problems in all tumor immunotherapies. Recent studies have shown that pyroptosis, a form of programmed cell death that is accompanied by immune checkpoint inhibitors, can induce effective immunogenic cell death and long‐term immune activation. Therapeutic strategies to jointly induce pyroptosis and reverse immunosuppressive tumor microenvironments are promising for cancer immunotherapy. In this regard, a dual‐responsive supramolecular polymeric nanomedicine (NCSNPs) to self‐cascade amplify the benefits of cancer immunotherapy is designed. The NCSNPs are formulated by β‐cyclodextrin coupling nitric oxide (NO) donor, a pyroptosis activator, and NLG919, an indoleamine 2,3‐dioxygenase (IDO) inhibitor, and self‐assembled through host–guest molecular recognition and hydrophobic interaction to obtain nanoparticles. NCSNPs possess excellent tumor accumulation and bioavailability attributed to ingenious supramolecular engineering. The study not only confirms the occurrence of NO‐triggered pyroptosis in tumors for the first time but also reverses the immunosuppressive microenvironment in tumor sites via an IDO inhibitor by enhancing the infiltration of cytotoxic T lymphocytes, to achieve remarkable inhibition of tumor proliferation. Thus, this study provides a novel strategy for cancer immunotherapy.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Hepatobiliary and Pancreatic Surgery, The Second Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, Zhejiang, 310009, China.
- The Second Affiliated Hospital of Zhejiang University, Key Laboratory of Precision Diagnosis and Treatment for Hepatobiliary and Pancreatic Tumor of Zhejiang Province, Hangzhou, Zhejiang, 310009, China.
- The Second Affiliated Hospital of Zhejiang University, Research Center of Diagnosis and Treatment Technology for Hepatocellular Carcinoma of Zhejiang Province, Hangzhou, Zhejiang, 310009, China.
- The Second Affiliated Hospital of Zhejiang University, Clinical Research Center of Hepatobiliary and Pancreatic Diseases of Zhejiang Province, Hangzhou, Zhejiang, 310009, China.
- Clinical Medicine Innovation Center of Precision Diagnosis and Treatment for Hepatobiliary and Pancreatic Disease, Zhejiang University, Hangzhou, Zhejiang, 310009, China.
- Cancer Center, Zhejiang University, Hangzhou, Zhejiang, 310009, China.
ORCID-Profile: Zhengwei Mao
Förderung
- National Natural Science Foundation of China
- Zhejiang University Basic Research Fund
- Plan Project of Wenzhou Municipal Science and Technology
- Fundamental Research Funds for the Central Universities
- Zhejiang Provincial Natural Science Foundation of China
- Chen Xiao-Ping Foundation for the Development of Science and Technology of Hubei Province
- Key Laboratory of Intelligent Preventive Medicine of Zhejiang Province
Zitieren
APA
Hu, W., Ye, B., Yu, G., Yang, H., Wu, H., Ding, Y., Huang, F., Wang, W., & Mao, Z. (2024). Dual‐Responsive Supramolecular Polymeric Nanomedicine for Self‐Cascade Amplified Cancer Immunotherapy. Advanced Science. https://doi.org/10.1002/advs.202305382
Vancouver
Hu W, Ye B, Yu G, Yang H, Wu H, Ding Y, et al. Dual‐Responsive Supramolecular Polymeric Nanomedicine for Self‐Cascade Amplified Cancer Immunotherapy. Advanced Science. 2024. doi:10.1002/advs.202305382
BibTeX
@article{Hu2024,
author = {Hu, Wenting and Ye, Binglin and Yu, Guocan and Yang, Huang and Wu, Hao and Ding, Yuan and Huang, Feihe and Wang, Weilin and Mao, Zhengwei},
title = {Dual‐Responsive Supramolecular Polymeric Nanomedicine for Self‐Cascade Amplified Cancer Immunotherapy},
journal = {Advanced Science},
year = {2024},
doi = {10.1002/advs.202305382}
}
EUVIMED